HomeInsightsStock Comparison

Dipna Pharmachem Ltd vs Sakar Healthcare Ltd Stock Comparison

Dipna Pharmachem Ltd vs Sakar Healthcare Ltd Stock Comparison

Last Updated on: Apr 25, 2025

Key Highlights

  • The Latest Trading Price of Dipna Pharmachem Ltd is ₹ 19.99 as of 25 Apr 15:30.
  • The P/E Ratio of Dipna Pharmachem Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Sakar Healthcare Ltd changed from 7.8 on March 2020 to 68.6 on March 2024 . This represents a CAGR of 54.47% over 5 years.
  • The Market Cap of Dipna Pharmachem Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Sakar Healthcare Ltd changed from ₹ 74.73 crore on March 2020 to ₹ 801.05 crore on March 2024 . This represents a CAGR of 60.71% over 5 years.
  • The revenue of Dipna Pharmachem Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sakar Healthcare Ltd for the Dec '24 is ₹ 43.71 crore as compare to the Sep '24 revenue of ₹ 43.15 crore. This represent the growth of 1.3%.
  • The ebitda of Dipna Pharmachem Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sakar Healthcare Ltd for the Dec '24 is ₹ 12 crore as compare to the Sep '24 ebitda of ₹ 11.87 crore. This represent the growth of 1.1%.
  • The net profit of Dipna Pharmachem Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Sakar Healthcare Ltd changed from ₹ 2.84 crore to ₹ 4.53 crore over 7 quarters. This represents a CAGR of 30.58% .
  • The Dividend Payout of Dipna Pharmachem Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sakar Healthcare Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Dipna Pharmachem Ltd

  • Dipan Pharmachem Private Limited was incorporated on July 19, 2011.
  • Subsequently, the Company name was changed to 'Dipna Pharmachem Private Limited' on March 29, 2012.
  • Later on, it was converted from Private Limited to Public Limited and the name of Company was changed to 'Dipna Pharmachem Limited' vide fresh Certificate of Incorporation issued by Registrar of Companies, Ahmedabad dated May 25, 2022. Mr. Keyur Shah, being the Promoter, the Company is engaged in trading and distribution of pharmaceutical raw material and chemical formulation products, also known as APIs (Active Pharmaceutical Ingredients).
  • Presently, its product portfolio comprises of 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovasculars, Anti - Bactaria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone, other etc.

About Sakar Healthcare Ltd

  • Sakar Healthcare Limited was incorporated as a Private Limited Company under the name 'Sakar Healthcare Private Limited on 26th March 2004.
  • Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to 'Sakar Healthcare Limited.
  • The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah. The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections and Oral Solid Dossages.
  • It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.

Dipna Pharmachem Ltd News Hub

News

Dipna Pharmachem EGM scheduled

Dipna Pharmachem announced that an Extra Ordinary General Meeting (EGM) of the Company wil...

Read more

13 Mar 2025 16:38

News

Dipna Pharmachem to hold board meeting

Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 12 March ...

Read more

08 Mar 2025 10:20

News

Dipna Pharmachem announces board meeting date

Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 24 Februa...

Read more

12 Feb 2025 11:34

News

Dipna Pharmachem to convene board meeting

Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 6 Februar...

Read more

31 Jan 2025 11:46

News

Dipna Pharmachem announces board meeting date

Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 29 July 2...

Read more

25 Jul 2024 10:30

News

Dipna Pharmachem to hold board meeting

Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 12 June 2...

Read more

11 Jun 2024 10:05

Sakar Healthcare Ltd News Hub

News

Sakar Healthcare to conduct board meeting

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 8 Februar...

Read more

03 Feb 2025 10:50

News

Sakar Healthcare schedules board meeting

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 22 Octobe...

Read more

18 Oct 2024 16:55

News

Sakar Healthcare to hold board meeting

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 13 August...

Read more

09 Aug 2024 16:37

News

Sakar Healthcare to convene AGM

Sakar Healthcare announced that the 20th Annual General Meeting (AGM) of the company will ...

Read more

23 Jul 2024 10:02

News

Sakar Healthcare to convene board meeting

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 21 May 20...

Read more

15 May 2024 16:27

News

Sakar Healthcare soars after oncology unit receives EU GMP approval

Sakar Healthcare announced today that its oncology unit located in Bavla, Gujarat, has rec...

Read more

06 Mar 2024 12:19

SWOT Analysis Of Dipna Pharmachem Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Sakar Healthcare Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Dipna Pharmachem Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sakar Healthcare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Dipna Pharmachem Ltd and Sakar Healthcare Ltd

Which company has a larger market capitalization, Dipna Pharmachem Ltd or Sakar Healthcare Ltd?

Market cap of Dipna Pharmachem Ltd is 48 Cr while Market cap of Sakar Healthcare Ltd is 638 Cr

What are the key factors driving the stock performance of Dipna Pharmachem Ltd and Sakar Healthcare Ltd?

The stock performance of Dipna Pharmachem Ltd and Sakar Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dipna Pharmachem Ltd and Sakar Healthcare Ltd?

As of April 25, 2025, the Dipna Pharmachem Ltd stock price is INR ₹19.99. On the other hand, Sakar Healthcare Ltd stock price is INR ₹291.03.

How do dividend payouts of Dipna Pharmachem Ltd and Sakar Healthcare Ltd compare?

To compare the dividend payouts of Dipna Pharmachem Ltd and Sakar Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions